HeiLongJiang ZBD Pharmaceutical(603567.SH): The application for listing of paroxetine hydrochloride, a chemical raw material medicine, has been approved.
13/02/2025
GMT Eight
Heilongjiang ZBD Pharmaceutical (603567.SH) announced that its Jixi branch received a "Approval Notice for Marketing Application of Chemical Raw Materials" issued by the National Medical Products Administration. The chemical raw material is Paroxetine Hydrochloride, used for treating various types of depression, including depression accompanied by anxiety and reactive depression.